Rhythm Pharmaceuticals, Inc. RYTM Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s operating lease liabilities?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported operating lease liabilities of $3.16M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s operating lease liabilities decreased by 17.6% year-over-year, from $3.84M to $3.16M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 14.5% compound annual growth rate (CAGR), from $1.95M to $3.34M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.